ADR of special interest

Patients, n (%)

All patients (N = 20,000)

At-risk patients

(N = 153)

Injection site warmth/and or feeling hot

119 (0.60)

1 (0.65)

Nausea and/or vomiting

200 (1.0)

4 (2.6)

Urticaria, erythema, rash and/or papular rash

94 (0.47)

4 (2.6)

Cough and/or sneezing

20 (0.10)

3 (2.0)

Dyspnea and /or bronchospasm

11 (0.06)

1 (0.65)

Blood pressure increase and/or decrease

6 (0.03)

0